Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology. more
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -2.95% | -2.17% |
| 1-Month Return | 6.51% | -3.58% |
| 3-Month Return | 5.99% | -2.67% |
| 6-Month Return | 23.94% | 1.47% |
| 1-Year Return | 23.59% | 9.81% |
| 3-Year Return | 51.57% | 70.48% |
| 5-Year Return | 15.75% | 61.7% |
| 10-Year Return | 143.62% | 246.88% |
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -79.01% | -68.14% |
| 1-Month Return | 115.40% | -35.82% |
| 3-Month Return | 26.61% | -10.39% |
| 6-Month Return | 54.53% | 3.00% |
| 1-Year Return | 23.59% | 9.81% |
| 3-Year Return | 14.87% | 19.46% |
| 5-Year Return | 2.97% | 10.09% |
| 10-Year Return | 9.31% | 13.24% |
| Stock name | Ticker | Weight |
|---|---|---|
Zimmer Biomet Holdings, Inc. | ZBH | 2.7% |
Centene Corporation | CNC | 2.68% |
Universal Health Services, Inc. (Class B) | UHS | 2.56% |
Halozyme Therapeutics, Inc. | HALO | 2.5% |
The Cigna Group | CI | 2.49% |
Globus Medical, Inc. (Class A) | GMED | 2.44% |
GE HealthCare Technologies Inc. | GEHC | 2.3% |
Medpace Holdings, Inc. | MEDP | 2.29% |
Solventum Corporation | SOLV | 2.22% |
DexCom, Inc. | DXCM | 2.2% |
Regeneron Pharmaceuticals, Inc. | REGN | 2.14% |
Eli Lilly and Company | LLY | 2.12% |
Exelixis, Inc. | EXEL | 2.11% |
Zoetis Inc. | ZTS | 2.11% |
Medtronic Plc | MDT | 2.09% |
The Cooper Companies, Inc. | COO | 2.02% |
Tenet Healthcare Corporation | THC | 2.01% |
Natera, Inc. | NTRA | 1.98% |
Amgen Inc. | AMGN | 1.96% |
Guardant Health, Inc. | GH | 1.93% |
Tempus AI, Inc. (Class A) | TEM | 1.93% |
Caris Life Sciences, Inc. | CAI | 1.91% |
United Therapeutics Corporation | UTHR | 1.88% |
Boston Scientific Corporation | BSX | 1.84% |
Bristol-Myers Squibb Company | BMY | 1.82% |
Jazz Pharmaceuticals Plc | JAZZ | 1.76% |
Incyte Corporation | INCY | 1.75% |
Steris Plc | STE | 1.52% |
HCA Healthcare, Inc. | HCA | 1.5% |
Labcorp Holdings Inc. | LH | 1.48% |
Encompass Health Corporation | EHC | 1.46% |
QIAGEN N.V. | QGEN | 1.46% |
Neurocrine Biosciences, Inc. | NBIX | 1.42% |
DaVita Inc. | DVA | 1.4% |
Ascendis Pharma A/S | ASND | 1.4% |
Elevance Health Inc. | ELV | 1.4% |
Corcept Therapeutics Inc. | CORT | 1.4% |
AbbVie Inc. | ABBV | 1.39% |
Align Technology, Inc. | ALGN | 1.38% |
Quest Diagnostics Incorporated | DGX | 1.38% |
ResMed Inc. | RMD | 1.36% |
Viatris Inc. | VTRS | 1.35% |
Revolution Medicines, Inc. | RVMD | 1.09% |
Becton, Dickinson and Company | BDX | 1.07% |
Doximity, Inc. (Class A) | DOCS | 1.05% |
Abbott Laboratories | ABT | 1.03% |
BridgeBio Pharma, Inc. | BBIO | 1.01% |
Biogen Inc. | BIIB | 0.97% |
Envista Holdings Corporation | NVST | 0.96% |
The Ensign Group, Inc. | ENSG | 0.95% |
Chemed Corporation | CHE | 0.95% |
Pfizer Inc. | PFE | 0.94% |
Vertex Pharmaceuticals Incorporated | VRTX | 0.93% |
Henry Schein, Inc. | HSIC | 0.91% |
Arrowhead Pharmaceuticals, Inc. | ARWR | 0.79% |
Madrigal Pharmaceuticals, Inc. | MDGL | 0.71% |
Axsome Therapeutics, Inc. | AXSM | 0.63% |
IDEXX Laboratories, Inc. | IDXX | 0.54% |
Stryker Corporation | SYK | 0.51% |
Intuitive Surgical, Inc. | ISRG | 0.48% |
Medline Inc. (Class A) | MDLN | 0.48% |
Veeva Systems Inc. (Class A) | VEEV | 0.46% |
Humana Inc. | HUM | 0.45% |
UnitedHealth Group Incorporated | UNH | 0.45% |
West Pharmaceutical Services, Inc. | WST | 0.44% |
Elanco Animal Health Incorporated | ELAN | 0.44% |
Johnson & Johnson | JNJ | 0.43% |
Danaher Corporation | DHR | 0.43% |
Thermo Fisher Scientific Inc. | TMO | 0.42% |
Agilent Technologies, Inc. | A | 0.42% |
Bio-Rad Laboratories, Inc. (Class A) | BIO | 0.41% |
Insmed Incorporated | INSM | 0.4% |
US Dollar | US.Dollar | 0.16% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
First Trust Health Care AlphaDEX® Fund (FXH) share price today is $139.4.
Yes, Indians can buy shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. To buy FXH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. You can start investing in First Trust Health Care AlphaDEX® Fund (FXH) with a minimum investment of $1.
The 52-week high price of First Trust Health Care AlphaDEX® Fund (FXH) is $143.96. The 52-week low price of First Trust Health Care AlphaDEX® Fund (FXH) is $104.12.
The stock symbol (or ticker) of First Trust Health Care AlphaDEX® Fund is FXH.
Yes, you can setup SIP in First Trust Health Care AlphaDEX® Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of FXH on the Vested app.
The expense ratio of First Trust Health Care AlphaDEX® Fund (FXH) is 0.58%.
Link copied